U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549

                                   Form 10K-SB

(Mark  one)
   [X] ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF
                1934 For the fiscal year ended December 31, 2002
                     -------------------------------------------
                                       OR
   [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
                                  ACT OF 1934

Commission  file  number:  0-33519
                           -------


                              Snocone Systems Inc.
                              --------------------
                 (Name of small business issuer in its charter)


    Nevada                                       #98-0360989
  ---------                                      -----------
(State or other jurisdiction of          (I.R.S. Employer Identification No)
incorporation or organization)

     #440,  1555  E.  Flamingo  Road,
     Las  Vegas,  Nevada  89119                         (604)  681  -7806
-------------------------------------                   ------------------
 (Address  of  principal  executive  offices) (Registrant's  phone  number)

Securities  registered  under  Section  12(b)  of  the  Act:
None
----

Securities  registered  under  Section  12(g)  of  the  Act:
Common  Stock,  par  value  $0.001  per  share
----------------------------------------------
(Title  of  class)

Check  whether  the Issuer (1) filed all reports required to be filed by Section
13  or  15(d)  of  the Securities Exchange Act during the past 12 months (or for
such  shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days.
(1)  Yes [ X ]  No  [   ]  (2)  Yes  [ X ]  No  [   ]

Check  if there is no disclosure of delinquent filers in response to Item 405 of
Regulation  S-B  contained in this form, and no disclosure will be contained, to
the  best  of  registrant's  knowledge,  in  definitive  proxy  or  information
statements  incorporated  by  reference  in  Part III of this Form 10-KSB or any
amendment  to  this  Form  10-KSB.  [  X  ]

Registrant's  revenues  for  its  most  recent  fiscal  year:     $nil
                                                              --------

State the aggregate market value of the voting and non-voting common equity held
by  non-affiliates  of  the  registrant.  The  aggregate  market  value shall be

                                        1
<PAGE>

computed  by  reference to the price at which the common equity was sold, or the
average  bid  and  asked  prices  of  such common equity, as of a specified date
within 60 days prior to the date of filing. (See definition of affiliate in Rule
405,  17  CFR  230.405)
Note  -  If  a  determination  as to whether a particular person or entity is an
affiliate  cannot be made without involving unreasonable effort and expense, the
aggregate  market  value  of  the  common  stock  held  by non-affiliates may be
calculated  on  the  basis  of  assumptions  reasonable under the circumstances,
provided  that  the  assumptions  are  set  forth  in  this  Form.
Aggregate  market  value  of  voting  common equity held by non-affiliates as of
December  31,  2002:
$  NIL
Aggregate  market value of non-voting common equity held by non-affiliates as of
December  31,  2002:  N/A

Indicate  whether  the  registrant  is  an accelerated filer based on the market
value  of  its  public  float
held  by non-affiliates at the end of the most recent second fiscal quarter:
[ ]  Yes        [X]  No

Indicate the number of shares outstanding of each of the registrant's classes of
common  stock,  as  of  the  latest  practicable  date.
Outstanding  shares  of  common  stock  as  of  December  31,  2002:  5,102,000
Outstanding  shares  of  preferred  stock  as  of  December  31,  2002:  Nil

Documents  incorporated  by  reference:  None

Transitional  Small  Business  Disclosure  Format:  Yes  [X]   No  [  ]

INDEX  to  Transitional Annual Report on Form 10-KSB for the Year Ended December
31,  2002
Part  I                                                                   Page
-------                                                                   ----
Item  1    Description  of  Business                                         3
Item  2    Description  of  Property                                         5
Item  3    Legal  Proceedings                                                5
Item  4    Submission of Matters to a Vote of Security Holders               5
Part  II
--------
Item  5    Market for Common Equity and Related Stockholder Matters          5
Item  6    Management's Discussion and Analysis of Financial
           Condition or Plan  of  Operation                                  5
Item  7    Financial  Statements                                             7
Item  8    Changes In and Disagreements With Accountants on
           Accounting and Financial Disclosure                              14
Part  III
---------
Item  9    Directors, Executive Officers, Promoters and Control
           Persons; Compliance With Section 16(a) of the Exchange Act       14
Item  10   Executive  Compensation                                          14
Item  11   Security Ownership of Certain Beneficial Owners and Management   15
Item  12   Certain  Relationships  and  Related  Transactions               15
Item  13   Exhibits  and Reports on Form 8-K                                15

Signatures                                                                  16

                                        2
<PAGE>

PART  I

ITEM  1.  DESCRIPTION  OF  BUSINESS

CORPORATE  BACKGROUND

Snocone  Systems  Inc.  ("Snocone"  or the "Company") was incorporated under the
laws  of  the  State of Nevada on October 12, 2000, under the name Cogen Systems
Inc.,  and is in its early developmental stage.  The Company changed its name to
Snocone  Systems  Inc.  on December 6, 2001.  To date, Snocone's only activities
have been organizational, directed at acquiring its principal asset, raising its
initial  capital  and developing its business plan. The Company has generated no
revenues  to  date, has no assets and has part-time management. In addition, the
Company's  auditors have expressed a going concern qualification with respect to
the  Company's  audited  financial  statements  at  December  31,  2002.

On  October  12,  2000,  Snocone  acquired  the  ownership  rights  to  certain
software  and  intellectual  property from Walter Williams, the developer of the
software,  who  was compensated  two thousand ($2,000) dollars and five thousand
(5,000  pre-split)  shares  of  Snocone  common stock.  The other 25 owners were
compensated  an  aggregate  of  ten  thousand  (10,000  pre-split)  shares.  On
December  7,  2001;  the  Company  conducted  a  200  for 1 forward stock split,
increasing  the number of shares of common stock held by  the  assignors  of the
assets  to  3,000,000  shares.

Snocone's  business  plan  is  to  produce  and  sell  its software, and related
products  and  services,  to  specific  target  markets.  The  software is being
designed  for  computer  analysis  of  genomic  and  proteomic  databases and is
expected  to  be  useful  to  genetic  researchers, research institutes, biotech
firms,  universities  and  other  similar  types of customers.  Snocone plans to
initially  market  the  software  by  participating  at tradeshows, seminars and
conventions.  Snocone  has not commenced commercial operations, has no full-time
employees  and  owns  no  real  estate.

Funding  Its  Business  Plan
----------------------------
The  expenses  of  implementing  the  Company's  business  plan  will exceed the
Company's  current  funding.  The  Company,  therefore,  will  have  to  obtain
additional  funding  through  an  offering  of its securities or through capital
contributions from its stockholders.  No commitments to provide additional funds
have  been  made  by  management  or stockholders.  Accordingly, there can be no
assurance that any additional funds will be available on terms acceptable to the
Company  or  at  all.  The  Company has found it difficult to attract investment
in  its  technology  and business concept and is currently undergoing a thorough
management  review  of  its  possibilities,  business  direction  and  available
opportunities.

Snocone  estimates  that  it  will  require US$125,000 to  achieve a sustainable
sales  level,  where  ongoing operations can be funded  out  of  revenues.  This
capital infusion is intended to cover costs of advertising,  hiring  and  paying
two  to  three  sales  people,  and  administrative  expenses.

The  Company  plans  to  utilize  debt  and/or  equity  financings  to  fund its
short-term  and  long-term  growth.  The  availability of future financings will
depend  on  market  conditions.  A  portion of the funds may be used to grow the
business  through  acquisition  of  other  businesses.

                                        3
<PAGE>

Snocone will need additional capital to carry out its business plan or to engage
in  a  combination  with another business, if such opportunity should arise.  No
commitments  to  provide  additional funds have been made by management or other
stockholders.  Accordingly,  there can be no assurance that any additional funds
will  be available on terms acceptable to Snocone or at all. Snocone has no firm
commitments  for  capital  expenditures  at  this  time.

Competition
-----------
Snocone  is  competing  for  financing  and investor attention with an unlimited
number  of  other businesses in their start up phase.  The Company is finding it
difficult  to  attract investor funding and to date has been unsuccessful in its
efforts  to  attract  financing.

Many  of  Snocone's  potential  competitors  for  funding  have longer operating
histories,  larger  customer  or  user  bases,  greater  brand  recognition  and
significantly  greater financial, marketing and other resources than Snocone has
as  it attempts to enter the marketplace.  In addition, existing competitors may
be  acquired  by,  receive  investments  from,  or  enter  into other commercial
relationships  with,  larger,  well-established  and  well-financed  companies.
Competitors  have  and  may continue to adopt aggressive pricing or availability
policies  and  devote substantially more resources to technology and methodology
development  than  Snocone.

Intellectual  Property
----------------------
The  Company recognizes the need to file patents, trademarks, and trade names on
the  unique  features  of  technology.  The  Company  currently  holds  no  such
registrations  of  its  intellectual property which it believes could be applied
for  and  should  be  applied  for  once  funding  is  available.

Government  Regulation
----------------------
In  general,  several  government  agencies,  such  as  the  Food  and  Drug
Administration  (FDA),  Environmental  Protection  Agency  (EPA), Copyrights and
Patents,  have  instigated specific laws and regulations which apply to genetics
and  other  research  activity.  It  is  possible  for  changes  to occur in the
regulatory  environment;  however,  the  precise applicability of these laws and
regulations  to  genetic  research is uncertain.  The vast majority of such laws
were  adopted  prior to the advent of effective DNA sequencing and, as a result,
do  not contemplate or address the unique issues of the research.  Nevertheless,
numerous  federal  and  state  government  agencies  have  already  demonstrated
significant  activity  in  promoting  bans  and  enforcing  other regulatory and
statutory  changes.

Additionally,  due to the increasing use of genetic information and research, it
is possible that new laws and regulations may be enacted with respect to the use
and availability of genetic information covering issues such as patient privacy,
cloning,  patenting,  pricing, ownership and standards of research and services,
manipulation,  intellectual  property  rights  and  information  security.  The
adoption  of such laws or regulations and the applicability of existing laws and
regulations to genetic information may impair the growth of genetic research and
result  in  a  decline  in  the  market  for  Snocone's  software.

Employees
---------
Currently,  the  Company  has  no  employees  and  relies  upon its officers and
directors  to  further  its  affairs.

                                        4
<PAGE>

ITEM  2.  DESCRIPTION  OF  PROPERTY
-----------------------------------

The  Company  does not currently own or lease any property.  The Company intends
to  find  a  suitable  space  in  the  future,  once funding is obtained and the
Company  is  able  to  pursue  its  business plan. Snocone's principal executive
offices  are  located at Suite 1200, 1090 West Pender Street, Vancouver, BC, V6E
2N7  where  it  shares office space at nominal rent; and its telephone number is
(604)  681-7806.

ITEM  3.  LEGAL  PROCEEDINGS
----------------------------
The  Company  is  not  party  to any pending legal proceeding or litigation  and
none  of  its  property  is  the  subject  of  a  pending  legal  proceeding.
Further,  the  Company  is  not aware of any legal proceedings against it or its
property.

ITEM  4.  SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS
---------------------------------------------------------------------

No matters were submitted to the stockholders during the year ended December 31,
2002.

PART  II

ITEM  5.  MARKET  FOR  COMMON  EQUITY  AND  RELATED  STOCKHOLDER  MATTERS
-------------------------------------------------------------------------

No  change  since  previous  filing

ITEM 6.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
--------------------------------------------------------------------------------
OF  OPERATIONS
--------------

Special  Note  Regarding  Forward  Looking  Statements

Certain statements in this report and elsewhere (such as in other filings by the
Company  with  the  Securities  and Exchange Commission ("SEC"), press releases,
presentations  by  the  Company  of  its  management  and  oral  statements) may
constitute  "forward-looking  statements"  within  the  meaning  of  the Private
Securities  Litigation  Reform  Act  of  1995.  Words  such  as  "expects,"
"anticipates,"  "intends,"  "plans,"  "believes,"  "seeks,"  "estimates,"  and
"should," and variations of these words and similar expressions, are intended to
identify  these forward-looking statements. Actual results may materially differ
from  any forward-looking statements.  Factors that might cause or contribute to
such  differences  include,  among  others, competitive pressures and constantly
changing  technology  and  market  acceptance  of  the  Company's  products  and
services.  The  Company  undertakes no obligation to publicly release the result
of  any  revisions  to  these  forward-looking  statements, which may be made to
reflect  events  or  circumstances  after  the  date  hereof  or  to reflect the
occurrence  of  unanticipated  events.

Overview
--------
Snocone is a Nevada corporation, incorporated on October 12, 2000.  Snocone is a
development  stage company that has acquired the intellectual property rights to
genetic  research software.  These rights were purchased on October 12, 2000 for
$2,000  and  15,000  shares  of  common  stock (pre-split) from Walter Williams,
currently  a  director of Snocone, and other investors in the development of the

                                        5
<PAGE>

software.  The  15,000  shares  (pre-split)  became 3,000,000 following board of
directors'  approval  of  a  200  for 1 forward stock split on December 7, 2001.

PLAN  OF  OPERATION
-------------------
Snocone's  business  is  still  in  its  development stage.  The Company has not
generated  any  revenue  to  date.  The  Company  planned to generate revenue by
completing  the  development  of  its genetic research software and then selling
licenses  to the software or providing use of the software via the Internet on a
subscription  basis.  In  addition,  the  Company  planned  to  offer  technical
assistance  and  training  to  its  customers to assist them with setting up and
using  the  software.

Snocone's  business  plan  has  been  to  finish developing its genetic research
software  products  and  commence marketing and selling its products and related
services  to  targeted  markets.  Over  the  past two months, the Company raised
$16,243  and used these funds in part to conduct an in depth market study of the
commercial  potential  for  its  software. (For the results of the study, please
see the sub-section "Plan of Operation" below.)

LIQUIDITY  AND  CAPITAL  RESOURCES
----------------------------------
No material commitments for capital expenditures were made during the year ended
December  31,  2002.  Snocone  remains  in  the  development  stage  and,  since
inception,  has  experienced  no  significant  change  in  liquidity  or capital
resources  or  stockholders'  equity.

The  Company  plans  to  utilize  debt  and/or  equity  financings  to  fund its
short-term  and  long-term  growth.  The  availability of future financings will
depend  on  market  conditions.  A  portion of the funds may be used to grow the
business  through  acquisition  of  other  businesses.

Snocone will need additional capital to carry out its business plan or to engage
in  a  combination  with another business, if such opportunity should arise.  No
commitments  to  provide  additional funds have been made by management or other
stockholders.  Accordingly,  there can be no assurance that any additional funds
will  be available on terms acceptable to Snocone or at all. Snocone has no firm
commitments  for  capital  expenditures  at  this  time.

The  forecast  of  the  period  of  time  through  which the Company's financial
resources  will be adequate to support operations is a forward-looking statement
that  involves  risks  and  uncertainties.  The  actual funding requirements may
differ  materially  from this as a result of a number of factors including plans
to rapidly expand its new operations.  The Company's auditors caution that there
can be no assurance that the Company will be able to continue as a going concern
or  achieve  material  revenues  or  profitable  operations.

Plan  of  Operation
-------------------
For  the  most  recent fiscal year, the company incurred a loss in the amount of
$50,793 compared to a loss of $470 in the previous year. Both years losses are a
result  of  organizational  expenses  and  expenses associated with setting up a
company  structure  to  begin  implementing  its  business  plan.  The  Company
anticipates  that  until  these  procedures  are completed, it will not generate
revenues,  and  may continue to operate at a loss thereafter, depending upon the
performance  of  the  business.

                                        6
<PAGE>

During  the  fiscal  year  ended  December  31,  2002, the Company spent $14,014
towards the research and evaluation of the market potential for its software and
for  a  market  feasibility  report.  The  report  stated  that  "Snocone  faces
overwhelming  barriers  if  it  wishes  to  compete  in  its target market", and
identified  five  substantial  barriers to success, including: (1) the market is
mature  and  comprised  of mainly academic customers, (2) competing products are
available at no cost to academic customers, (3) competitors (mainly universities
and  research institutions) have substantial funding in the $USD multi-millions,
(4)  Snocone  lacks  industry  personnel  and  contacts,  and (5) Snocone has no
history  and  accomplishments  in  the  industry.

The  report  concluded:  "it  appears unlikely that the Snocone software product
would  succeed  in  the  human  genome  research  market."

During  the  period  from  October  12,  2000  (date  of  incorporation) through
December 31, 2002,  the  Company  has  engaged  in  no   significant  operations
other  than  organizational   activities.  The  Company  received  no  revenues
during  this  period.

For  the  current  fiscal  year ending December 31, 2002, the Company incurred a
loss  as  a  result  of  organizational  expenses  and  expenses associated with
implementing  its  business  plan.  The  Company  anticipates  that  until these
procedures  are  completed,  it  will not generate revenues, and may continue to
operate  at  a  loss thereafter, depending upon the performance of its business.
Accordingly,  there  can  be  no  assurance  that  any  additional funds will be
available  on  terms  acceptable  to  the  Company or at all. The Company has no
commitments  for  capital  expenditures.  In  the  process  of  carrying out its
business plan, the Company may determine that it cannot raise sufficient capital
to  support  its business on acceptable terms, or at all. The possibility exists
that  the  board of directors may decide that it is in the best interests of the
corporation  and  its  stockholders  to  enter  into  a  new  line  of  business
altogether.

ITEM  7.  FINANCIAL  STATEMENTS
-------------------------------

Independent  Auditors'  Report                                                 8

Balance  Sheets  as  at  December  31,  2002  and  2001  (audited)             9

Statements of Operations for the years ended December 31, 2002 and 2001 and for
The period from inception (October 12, 2000)through December 31, 2000(audited)10

Statements of Cash Flows for the year ended December 31, 2002 and 2001 and for
the period from inception (October 12, 2000) to December 31, 2000 (audited)   11

Statement of Stockholder's Equity for the period from inception (October 12,
2000)  to December  31,  2002  (audited)                                      12

Notes  to  the  Financial  Statements                                         13


                                        7
<PAGE>




                                                                [GRAPHIC OMITED]



                                                                [GRAPHIC OMITED]



                                AUDITORS' REPORT




To  the  Stockholders  and  Directors
Snocone  Systems  Inc.
(A  Development  Stage  Company)

We  have audited the balance sheets of Snocone Systems Inc. (a development stage
company)  as  at  December  31, 2002 and 2001, and the statements of operations,
stockholders'  deficiency,  and cash flows for the years ended December 31, 2002
and  2001,  and  for  the  period  from  October 12, 2000 (date of inception) to
December  31,  2002.  These  financial  statements are the responsibility of the
Company's  management.  Our  responsibility  is  to  express an opinion on these
financial  statements  based  on  our  audits.

We  conducted  our  audits in accordance with United States of America generally
accepted  auditing  standards.  Those standards require that we plan and perform
an  audit  to  obtain  reasonable assurance whether the financial statements are
free  of  material  misstatement.  An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements.  An
audit  also  includes  assessing  the accounting principles used and significant
estimates  made  by  management,  as  well  as  evaluating the overall financial
statement  presentation.  We  believe that our audit provides a reasonable basis
for  our  opinion.

In  our  opinion,  these  financial  statements  present fairly, in all material
respects,  the  financial  position  of  the Company as at December 31, 2002 and
2001,  and  the  results  of  its  operations and cash flows for the years ended
December  31,  2002  and 2001, and for the period from October 12, 2000 (date of
inception)  to  December  31,  2002  in accordance with United States of America
generally  accepted  accounting  principles.

The  accompanying  financial  statements  have  been  prepared assuming that the
Company  will  continue  as  a  going  concern.  As  discussed  in Note 1 to the
financial  statements,  the  Company  has suffered recurring losses and net cash
outflows from operations since inception.  These factors raise substantial doubt
about  the Company's ability to continue as a going concern.  Management's plans
in  regard  to  these  matters  are  also  discussed in Note 1.  These financial
statements  do not include any adjustments that might result from the outcome of
this  uncertainty.




Vancouver,  B.C.     "Morgan  &  Company"
March  28,  2003     Chartered  Accountants



                               [GRAPHIC  OMITED]



                               [GRAPHIC  OMITED]



                                        8
<PAGE>

Snocone  Systems  Inc.
(A  Development  Stage  Company)
Balance  Sheets
(expressed  in  U.S.  dollars)



                                                     December 31,   December 31,
                                                         2002               2001
                                                          $                  $

Assets
Cash                                                       7,007               0


Liabilities  and  Stockholders'  Equity

Current  Liabilities

Accounts  payable                                         47,628           6,228


Contingent  Liability  (Note  1)

Stockholders'  Deficiency

Common  Stock:
25,000,000 shares authorized with a par value of $.001;    5,102           5,000
 5,102,000 shares issued and outstanding (5,000,000 prior year)

Additional  Paid-in  Capital                              16,298               0

                                                          21,400           5,000

Deficit Accumulated  During  the  Development  Stage     (62,021)       (11,228)

                                                         (40,621)        (6,228)

                                                           7,007               0


(The  accompanying  notes  are  an  integral  part  of the financial statements)

                                        9
<PAGE>


Snocone  Systems  Inc.
(A  Development  Stage  Company
Statements  of  Operations
(expressed  in  U.S.  dollars)

                           Accumulated                                From
                              from                                October 12,
                           October 12,    For the      For the       2000
                         2000 (Date of     Year          Year       (Date of
                         Inception) to     Ended        Ended       Inception)
                          December 31,    December     December    to December
                             2002         31, 2002     31, 2001     31, 2000
                               $               $        $              $



Expenses

Marketing feasibility           14,014       14,014           0            0
Administration                  12,650       12,650
Rent                             6,000        6,000           0            0
Professional fees               14,730       14,730
Office                           3,399        3,399           0            0
Organization expenses            6,228            0         470        5,758
Technology cost                  5,000            0           0        5,000
                                62,021       50,793         470       10,758
Net  Loss                      (62,021)     (50,793)       (470)     (10,758)

Net  Loss  Per  Share                        (0.00)       (0.00)      (0.00)

Weighted Average Shares Outstanding       5,011,000   5,000,000    5,000,000


(The accompanying notes are  an  integral  part  of the financial statements)
                                       10
<PAGE>

Snocone  Systems  Inc.
(A  Development  Stage  Company
Statements  of  Cash  Flows
(expressed  in  U.S.  dollars)


                           Accumulated                                From
                                from                                October 12,
                             October 12,    For the      For the       2000
                           2000 (Date of     Year          Year       (Date of
                           Inception) to     Ended        Ended      Inception)
                            December 31,    December     December   to December
                               2002         31, 2002     31, 2001     31, 2000
                                 $               $        $              $
Cash Flows to Operating
Activities
Net loss                       (62,021)     (50,793)       (470)       (10,758)

Non cash items

Expenses not paid with cash      5,000            0           0          5,000
Accounts payable                47,628       41,400         470          5,758

Net Cash Used by Operating
Activities                      (9,393)      (9,393)          0              0

Net  Cash  Provided  by
Financing  Activities:
Issuance  of common stock       16,400       16,400           0              0

Net Cash Used by Investing
Activities                           0            0           0              0

Change in cash                   7,007        7,007           0              0

Cash - beginning of period           0            0           0              0

Cash  -  end  of  period         7,007        7,007           0              0


Non-Cash  Financing  Activities

A total of 3,000,000 shares
were issued for the
acquisition of technology        3,000             0          0          3,000

A total of 2,000,000 shares
were issued for organization
of  the Company                  2,000             0          0          2,000

                                 5,000             0          0          5,000


(The accompanying notes are an integral  part  of the financial statements)

                                       11
<PAGE>
Snocone  Systems  Inc.
(A  Development  Stage  Company)
Statement  of  Stockholders'  Equity
From  October  12,  2000  (Date  of  Inception)  to  December  31,  2002
(expressed  in  U.S.  dollars)


                                                                       Deficit
                                                                     Accumulated
                                                   Additional         During the
                                  Common Stock      Paid-in          Development
                                Shares    Amount    Capital    Total     Stage
                                   #         $         $         $         $

Balance - October 12, 2000
(Date of Inception)                  0         0         0         0           0

Stock issued for  $2,000
of organization expenses     2,000,000     2,000         0     2,000           0

Stock issued for technology  3,000,000     3,000         0     3,000           0

Net  loss  for  the  period          0         0         0         0    (10,758)

Balance - December 31, 2000  5,000,000     5,000         0     5,000    (10,758)

Net loss for the year                0         0         0         0       (470)

Balance - December 31, 2001  5,000,000     5,000         0     5,000    (11,228)

Stock issued for cash          102,000       102    16,298    16,400           0

Net loss for the year                0         0         0         0    (50,793)

Balance - December 31, 2002  5,102,000     5,102    16,298    21,400    (62,021)


(The  accompanying  notes  are  an  integral  part  of the financial statements)

                                       12
<PAGE>

Snocone  Systems  Inc.
(A  Development  Stage  Company)
Notes  to  Financial  Statements
(expressed  in  U.S.  dollars)

1.     Development  Stage  Company

     Snocone  Systems  Inc. herein (the "Company") was incorporated in the State
     of Nevada on October 12, 2000, under the name Cogen Systems Inc., and is in
     its  early  developmental  stage.  The  Company changed its name to Snocone
     Systems  Inc.  on  December 6, 2001. To date, the Company's only activities
     have  been  organizational,  directed  at  acquiring  its  principal asset,
     raising  its  initial  capital  and  developing  its  business  plan.

     On  October  12, 2000, the Company acquired the ownership rights to certain
     software  and  intellectual  property.  The  intellectual  property  assets
     acquired  include  all licensing, modification, marketing, distribution and
     sales  rights worldwide in perpetuity. Under the terms of the Agreement and
     Assignment of Intellectual Property Rights, the Company made a cash payment
     of  two  thousand  ($2,000)  dollars  and  issued fifteen thousand (15,000)
     shares  of the Company's common stock, now three million (3,000,000) shares
     following  a  forward  stock  split  that  was  authorized  by the Board of
     Directors  on  December  7, 2001. A copy of the Agreement and Assignment of
     Intellectual Property Rights is included as an exhibit to this registration
     statement.

     Since  inception,  the  Company  has suffered recurring losses and net cash
     outflows  from  operations.  The  Company  expects  to  continue  to  incur
     substantial  losses  to complete the development of its business. Since its
     inception, the Company has funded operations through common stock issuances
     and the support of its creditors in order to meet its strategic objectives.
     Management  believes  that sufficient funding will be available to meet its
     business  objectives, including anticipated cash needs for working capital,
     and  is  currently evaluating several financing options, including a public
     offering of securities. However, there can be no assurance that the Company
     will be able to obtain sufficient funds to continue the development of and,
     if  successful, to commence the sale of, its products under development. As
     a  result  of  the  foregoing,  there  exists  substantial  doubt about the
     Company's  ability  to  continue  as  a  going  concern.  These  financial
     statements  do  not  include  any  adjustments  that  might result from the
     outcome  of  this  uncertainty.

2.     Summary  of  Significant  Accounting  Policies

     (a)     Year  end

          The  Company's  fiscal  year  end  is  December  31.

     (b)     Software  Development  Costs

          The  costs  to  develop  new  software  products  and  enhancements to
          existing  software  products  will  be  expensed  as  incurred  until
          technological  feasibility  has  been  established. Once technological
          feasibility  has  been  established,  any  additional  costs  will  be
          capitalized.

     (c)     Use  of  Estimates

          The  preparation  of financial statements in conformity with generally
          accepted  accounting  principles requires management to make estimates
          and  assumptions  that  affect  the  reported  amounts  of  assets and
          liabilities and disclosure of contingent assets and liabilities at the
          date  of the financial statements and the reported amounts of revenues
          and  expenses  during  the  periods.  Actual results could differ from
          those  estimates.

                                       13
<PAGE>

      (d)  Net  Loss  Per  Share

          Net  loss per share is calculated using the weighted average number of
          common  shares  outstanding  during the period. Fully diluted loss per
          share  is  not  presented  as the impact of the exercise of options is
          anti-dilutive.

3.     Related  Party  Transaction

     An  individual  who  became  a  director of the Company on December 7, 2001
     received  $2,000  cash  and  1,000,000  common  shares  pursuant  to  the
     acquisition  of  technology.

4.     Subsequent Event

     Subsequent to December 31, 2002, the Company issued 20,000 shares of common
     stock for cash consideration of $3,200.

ITEM  8.  CHANGES  IN  AND  DISAGREEMENTS  WITH  ACCOUNTANTS  ON  ACCOUNTING AND
--------------------------------------------------------------------------------
FINANCIAL  DISCLOSURE
---------------------

There  are  no  reportable  disagreements  on accounting or financial disclosure
issues.

PART  III

ITEM  9.  DIRECTORS,  EXECUTIVE  OFFICERS,  PROMOTERS  AND  CONTROL  PERSONS
----------------------------------------------------------------------------

This  table sets forth the name, age and position of each director and executive
officer  of  the  Company  :

     NAME              AGE     POSITION
     ----              ---     --------
     Mona  Remedios     33     President,  Secretary,
                               Treasurer  and  Director
     Piers  VanZiffle   55     Director
     Walter  Williams   38     Director - Resigned November 1, 2002

ITEM  10.  EXECUTIVE  COMPENSATION
----------------------------------
No  officer  or  director  of the Company has received any remuneration from the
Company.


                                       14
<PAGE>

ITEM  11.  SECURITY  OWNERSHIP  OF  CERTAIN  BENEFICIAL  OWNERS  AND  MANAGEMENT
--------------------------------------------------------------------------------

                                                    NUMBER  OF     PERCENTAGE OF
     NAME                                         SHARES  HELD      SHARES OWNED
     ----                                         ------------     -------------
     Mona  Remedios,  President  and  Director       1,000,000          20.0%
     #3  -  849  Tobruk  Ave.
     North  Vancouver,  BC  V7P  1V9  CANADA

     Piers  Van  Ziffle,  Director                   1,000,000          20.0%
     #1455  -  409  Granville  Street
     Vancouver  B.C.,  V6C  1T2,  CANADA

     Walter  Williams                                1,000,000          20.0%
     #26,  16128  -  86th  Avenue
     Surrey,  BC  V4N  3T9  CANADA

     ALL  EXECUTIVE  OFFICERS  AND                   2,000,000          40.0%
     DIRECTORS  AS  A  GROUP  (3  persons)

ITEM  12.  CERTAIN  RELATIONSHIPS  AND  RELATED  TRANSACTIONS
-------------------------------------------------------------

No  change  since  previous  filing.

PART  IV

ITEM  13.  EXHIBITS  AND  REPORTS  ON  FORM  8-K
------------------------------------------------

EXHIBITS:  None.

REPORTS  ON  FORM  8-K:  None.

ITEM  14.  CONTROLS  AND  PROCEDURES
------------------------------------

Within  90  days  prior  to  the date of this report, the Company carried out an
evaluation,  under  the  supervision and with the participation of the Company's
management,  including  the  Company's  Executive  and Financial Officer, of the
effectiveness  of  the  design  and  operation  of  the Company's disclosure and
control  procedures.  Based  upon  that  evaluation,  the  Chief  executive  and
Financial Officer concluded that the Company's disclosure and control procedures
are  effective.  There  were  no  significant  changes in the Company's internal
controls or in other factors that could significantly affect these subsequent to
the  date  of  their  evaluation.

                                       15
<PAGE>


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has  been  signed below by the following persons on behalf of the registrant and
in  the  capacities  and  on  the  dates  indicated.

                      (Registrant)     SNOCONE SYSTEMS INC.

Date:    March  28,  2003                    By:    /s/  Mona  Remedios
      -------------------                           ---------------------
                                           Name:         Mona  Remedios
                                                    ---------------------
                                          Title:    President,  Secretary  and
                                                    --------------------------
                                                    Treasurer
                                                    ---------


                                302 CERTIFICATION

I,  Mona  Remedios,  Chief  Financial  Officer,  certify  that:
     1. I have reviewed this annual report  on  Form  10-KSB  of Snocone Systems
Inc.;
     2. Based on my knowledge, this report does not contain any untrue statement
of  a  material  fact  or  omit  to  state a material fact necessary to make the
statements  made, in light of the circumstances under which such statements were
made,  not  misleading with respect to the period covered by this annual report;
     3.  Based  on  my  knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of,  and  for,  the  periods  presented  in  this  annual  report;
     4.  The  registrant's other certifying officers and I have disclosed, based
on  our  most  recent  evaluation,  to  the  registrant's auditors and the audit
committee  of  registrant's  board  of  directors  (or  persons  performing  the
equivalent  functions):
          a) all significant deficiencies in the design or operation of internal
controls  which  could  adversely  affect  the  registrant's  ability to record,
process,  summarize  and  report  financial  data  and  have  identified for the
registrant's  auditors  any  material  weaknesses  in  internal  controls;  and
          b)  any  fraud,  whether  or not material, that involves management or
other  employees  who  have  a  significant  role  in  the registrant's internal
controls;  and
     5.  The registrant's other certifying officers and I have indicated in this
annual  report whether there were significant changes in internal controls or in
other  factors  that  could significantly affect internal controls subsequent to
the  date  of  our most recent evaluation, including any corrective actions with
regard  to  significant  deficiencies  and  material  weaknesses.

Date:  March  28,  2003                  /s/  Mona Remedios
                                        ------------------------
                                        Mona Remedios, Chief Financial Officer

                                       16
<PAGE>

                                  EXHIBIT 99.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In  connection  with  the  Annual  Report  of  Snocone  Systems  Inc.  (the
"Company")  on Form 10-KSB for the period ended December 31, 2002, as filed with
the  Securities  and  Exchange  Commission on the date hereof (the "Report"), I,
Mona  Remedios,  Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C  1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act of 2002, that:
     (1)  The  Report  fully  complies with the requirements of section 13(a) or
15(d)  of  the  Securities  Exchange  Act  of  1934;  and
     (2)  The  information  contained  in  the  Report  fairly  presents, in all
material  respects,  the  financial  condition  and  result of operations of the
Company.

/s/  Mona  Remedios
________________________
Title:       Chief  Executive  Officer  and  Chief  Financial  Officer
Date:        March  28,  2003